Inmune Bio Stock Technical Analysis
| INMB Stock | USD 9.58 0.81 7.80% |
As of the 16th of April 2024, INmune Bio retains the Risk Adjusted Performance of (0.03), market risk adjusted performance of (0.16), and Standard Deviation of 4.82. INmune Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We have collected data for thirteen technical drivers for INmune Bio, which can be compared to its competitors. Please check out INmune Bio variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if INmune Bio is priced fairly, providing market reflects its last-minute price of 9.58 per share. Given that INmune Bio has information ratio of (0.08), we strongly advise you to confirm INmune Bio's regular market performance to make sure the company can sustain itself at a future point.
INmune Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as INmune, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to INmuneINmune |
INmune Bio Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 17.33 | Strong Buy | 3 | Odds |
Most INmune analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand INmune stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of INmune Bio, talking to its executives and customers, or listening to INmune conference calls.
INmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
INmune Bio Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of INmune Bio volatility. High ATR values indicate high volatility, and low values indicate low volatility.
INmune Bio Trend Analysis
Use this graph to draw trend lines for INmune Bio. You can use it to identify possible trend reversals for INmune Bio as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual INmune Bio price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.INmune Bio Best Fit Change Line
The following chart estimates an ordinary least squares regression model for INmune Bio applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that INmune Bio market price will keep on failing further. It has 122 observation points and a regression sum of squares at 31.31, which is the sum of squared deviations for the predicted INmune Bio price change compared to its average price change.About INmune Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of INmune Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of INmune Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on INmune Bio price pattern first instead of the macroeconomic environment surrounding INmune Bio. By analyzing INmune Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of INmune Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to INmune Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 14.51 | 10.98 | 8.92 | 5.75 | Receivables Turnover | 0.0329 | 0.0442 | 0.0635 | 0.0603 |
INmune Bio April 16, 2024 Technical Indicators
Most technical analysis of INmune help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for INmune from various momentum indicators to cycle indicators. When you analyze INmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.75 | |||
| Coefficient Of Variation | (1,539) | |||
| Standard Deviation | 4.82 | |||
| Variance | 23.25 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.42) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 22.8 | |||
| Value At Risk | (7.76) | |||
| Potential Upside | 6.81 | |||
| Skewness | 0.2946 | |||
| Kurtosis | 0.7392 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INmune Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is INmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.67) | Revenue Per Share 0.009 | Quarterly Revenue Growth (0.71) | Return On Assets (0.27) | Return On Equity (0.61) |
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if INmune Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.